Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction.

Journal of experimental & clinical cancer research : CR·2025

Same author

MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction.

Journal of experimental & clinical cancer research : CR·2025

Same author

TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors.

Cancer immunology, immunotherapy : CII·2024

Same author

A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer.

Biomedicines·2023

Same author

Robust formation of optimal single spheroids towards cost-effective in vitro three-dimensional tumor models.

FEBS open bio·2023

Same author

A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells.

International journal of molecular sciences·2023

Search research articles

Related Experiment Video

Updated: Feb 16, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

Targeting cellular pathways in glioblastoma multiforme.

Joshua R D Pearson¹, Tarik Regad¹

¹The John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham, UK.

Signal Transduction and Targeted Therapy

|December 22, 2017

Summary

Glioblastoma multiforme (GBM) is a deadly brain cancer with poor outcomes. Understanding its complex cellular pathway alterations is key to developing effective glioblastoma treatments and improving patient survival.

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Related Experiment Videos

Last Updated: Feb 16, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Area of Science:

Neuro-oncology
Molecular Biology
Cancer Research

Background:

Glioblastoma multiforme (GBM) presents a significant clinical challenge due to its aggressive nature, poor prognosis, and limited therapeutic responses.
The pathogenesis of GBM is intricate, involving dysregulation of critical cellular pathways such as proliferation, survival, migration, and angiogenesis.
A deeper comprehension of GBM's molecular underpinnings is crucial for advancing treatment strategies.

Purpose of the Study:

To review the common molecular alterations implicated in glioblastoma multiforme pathogenesis.
To summarize current and emerging therapeutic strategies targeting aberrant cellular pathways in GBM.
To provide insights into developing more effective treatments for glioblastoma.

Main Methods:

Comprehensive literature review of studies on glioblastoma pathogenesis.
Analysis of key cellular pathways frequently altered in GBM.
Synthesis of information on therapeutic interventions targeting these pathways.

Main Results:

Identification of frequently mutated and altered cellular pathways in GBM.
Overview of therapeutic approaches including targeted therapies and pathway inhibitors.
Highlighting the link between specific molecular alterations and treatment responses.

Conclusions:

Targeting aberrant cellular pathways in GBM holds promise for improving therapeutic efficacy.
Continued research into GBM molecular pathogenesis is essential for developing novel and effective treatments.
Enhanced understanding can lead to improved patient survival and quality of life for glioblastoma patients.